Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Rouillé Y[au]:

Recent advances in human viruses imaging studies. Florian PE et al. J Basic Microbiol. (2016)

An ecological approach to discover new bioactive extracts and products: the case of extremophile plants. Sahli R et al. J Pharm Pharmacol. (2017)

Entry and Release of Hepatitis C Virus in Polarized Human Hepatocytes. Belouzard S et al. J Virol. (2017)

Search results

Items: 1 to 50 of 91

1.

The C-terminal domain of the MERS coronavirus M protein contains a trans-Golgi network localization signal.

Perrier A, Bonnin A, Desmarets L, Danneels A, Goffard A, Rouillé Y, Dubuisson J, Belouzard S.

J Biol Chem. 2019 Sep 27;294(39):14406-14421. doi: 10.1074/jbc.RA119.008964. Epub 2019 Aug 9.

PMID:
31399512
2.

Dehydrojuncusol, a Natural Phenanthrene Compound Extracted from Juncus maritimus, Is a New Inhibitor of Hepatitis C Virus RNA Replication.

Sahuc ME, Sahli R, Rivière C, Pène V, Lavie M, Vandeputte A, Brodin P, Rosenberg AR, Dubuisson J, Ksouri R, Rouillé Y, Sahpaz S, Séron K.

J Virol. 2019 May 1;93(10). pii: e02009-18. doi: 10.1128/JVI.02009-18. Print 2019 May 15.

3.

QuantIF: An ImageJ Macro to Automatically Determine the Percentage of Infected Cells after Immunofluorescence.

Handala L, Fiore T, Rouillé Y, Helle F.

Viruses. 2019 Feb 19;11(2). pii: E165. doi: 10.3390/v11020165.

4.

Functional and Physical Interaction between the Arf Activator GBF1 and Hepatitis C Virus NS3 Protein.

Lebsir N, Goueslain L, Farhat R, Callens N, Dubuisson J, Jackson CL, Rouillé Y.

J Virol. 2019 Mar 5;93(6). pii: e01459-18. doi: 10.1128/JVI.01459-18. Print 2019 Mar 15.

5.

Theaflavins, polyphenols of black tea, inhibit entry of hepatitis C virus in cell culture.

Chowdhury P, Sahuc ME, Rouillé Y, Rivière C, Bonneau N, Vandeputte A, Brodin P, Goswami M, Bandyopadhyay T, Dubuisson J, Séron K.

PLoS One. 2018 Nov 28;13(11):e0198226. doi: 10.1371/journal.pone.0198226. eCollection 2018.

6.

Investigation of the role of GBF1 in the replication of positive-sense single-stranded RNA viruses.

Ferlin J, Farhat R, Belouzard S, Cocquerel L, Bertin A, Hober D, Dubuisson J, Rouillé Y.

J Gen Virol. 2018 Aug;99(8):1086-1096. doi: 10.1099/jgv.0.001099. Epub 2018 Jun 20.

PMID:
29923822
7.

Endospanin-2 enhances skeletal muscle energy metabolism and running endurance capacity.

Lancel S, Hesselink MK, Woldt E, Rouillé Y, Dorchies E, Delhaye S, Duhem C, Thorel Q, Mayeuf-Louchart A, Pourcet B, Montel V, Schaart G, Beton N, Picquet F, Briand O, Salles JP, Duez H, Schrauwen P, Bastide B, Bailleul B, Staels B, Sebti Y.

JCI Insight. 2018 May 3;3(9). pii: 98081. doi: 10.1172/jci.insight.98081.

8.

Correction for Belouzard et al., "Entry and Release of Hepatitis C Virus in Polarized Human Hepatocytes".

Belouzard S, Danneels A, Fénéant L, Séron K, Rouillé Y, Dubuisson J.

J Virol. 2018 Apr 27;92(10). pii: e00309-18. doi: 10.1128/JVI.00309-18. Print 2018 May 15. No abstract available.

9.

Identification of Piperazinylbenzenesulfonamides as New Inhibitors of Claudin-1 Trafficking and Hepatitis C Virus Entry.

Riva L, Song OR, Prentoe J, Helle F, L'homme L, Gattolliat CH, Vandeputte A, Fénéant L, Belouzard S, Baumert TF, Asselah T, Bukh J, Brodin P, Cocquerel L, Rouillé Y, Dubuisson J.

J Virol. 2018 Apr 27;92(10). pii: e01982-17. doi: 10.1128/JVI.01982-17. Print 2018 May 15.

10.

Identification of GBF1 as a cellular factor required for hepatitis E virus RNA replication.

Farhat R, Ankavay M, Lebsir N, Gouttenoire J, Jackson CL, Wychowski C, Moradpour D, Dubuisson J, Rouillé Y, Cocquerel L.

Cell Microbiol. 2018 Jan;20(1). doi: 10.1111/cmi.12804. Epub 2017 Nov 17.

PMID:
29112323
11.

Entry and Release of Hepatitis C Virus in Polarized Human Hepatocytes.

Belouzard S, Danneels A, Fénéant L, Séron K, Rouillé Y, Dubuisson J.

J Virol. 2017 Aug 24;91(18). pii: e00478-17. doi: 10.1128/JVI.00478-17. Print 2017 Sep 15. Erratum in: J Virol. 2018 Apr 27;92 (10 ):.

12.

An ecological approach to discover new bioactive extracts and products: the case of extremophile plants.

Sahli R, Rivière C, Neut C, Bero J, Sahuc ME, Smaoui A, Beaufay C, Roumy V, Hennebelle T, Rouillé Y, Quetin-Leclercq J, Séron K, Ksouri R, Sahpaz S.

J Pharm Pharmacol. 2017 Aug;69(8):1041-1055. doi: 10.1111/jphp.12728. Epub 2017 Apr 26.

PMID:
28444868
13.

Novel replicons and trans-encapsidation systems for Hepatitis C Virus proteins live imaging and virus-host interaction proteomics.

Vlaicu O, Selescu T, Pastrama F, Munteanu C, Riva L, Dubuisson J, Rouille Y, Popescu CI.

J Virol Methods. 2017 Aug;246:42-50. doi: 10.1016/j.jviromet.2017.04.009. Epub 2017 Apr 21.

PMID:
28438609
14.

Identification of Novel Functions for Hepatitis C Virus Envelope Glycoprotein E1 in Virus Entry and Assembly.

Haddad JG, Rouillé Y, Hanoulle X, Descamps V, Hamze M, Dabboussi F, Baumert TF, Duverlie G, Lavie M, Dubuisson J.

J Virol. 2017 Mar 29;91(8). pii: e00048-17. doi: 10.1128/JVI.00048-17. Print 2017 Apr 15.

15.

Endospanin1 affects oppositely body weight regulation and glucose homeostasis by differentially regulating central leptin signaling.

Vauthier V, Roujeau C, Chen P, Sarkis C, Migrenne S, Hosoi T, Ozawa K, Rouillé Y, Foretz M, Mallet J, Launay JM, Magnan C, Jockers R, Dam J.

Mol Metab. 2016 Nov 3;6(1):159-172. doi: 10.1016/j.molmet.2016.10.009. eCollection 2017 Jan.

16.

Identification of a New Benzimidazole Derivative as an Antiviral against Hepatitis C Virus.

Vausselin T, Séron K, Lavie M, Mesalam AA, Lemasson M, Belouzard S, Fénéant L, Danneels A, Rouillé Y, Cocquerel L, Foquet L, Rosenberg AR, Wychowski C, Meuleman P, Melnyk P, Dubuisson J.

J Virol. 2016 Sep 12;90(19):8422-34. doi: 10.1128/JVI.00404-16. Print 2016 Oct 1.

17.

Recent advances in human viruses imaging studies.

Florian PE, Rouillé Y, Ruta S, Nichita N, Roseanu A.

J Basic Microbiol. 2016 Jun;56(6):591-607. doi: 10.1002/jobm.201500575. Epub 2016 Apr 5. Review.

PMID:
27059598
18.

Morphology and Molecular Composition of Purified Bovine Viral Diarrhea Virus Envelope.

Callens N, Brügger B, Bonnafous P, Drobecq H, Gerl MJ, Krey T, Roman-Sosa G, Rümenapf T, Lambert O, Dubuisson J, Rouillé Y.

PLoS Pathog. 2016 Mar 3;12(3):e1005476. doi: 10.1371/journal.ppat.1005476. eCollection 2016 Mar.

19.

Hexim1, a Novel Regulator of Leptin Function, Modulates Obesity and Glucose Disposal.

Dhar-Mascareno M, Ramirez SN, Rozenberg I, Rouille Y, Kral JG, Mascareno EJ.

Mol Endocrinol. 2016 Mar;30(3):314-24. doi: 10.1210/me.2015-1211. Epub 2016 Feb 9.

20.

Khaya grandifoliola C.DC: a potential source of active ingredients against hepatitis C virus in vitro.

Galani BR, Sahuc ME, Sass G, Njayou FN, Loscher C, Mkounga P, Deloison G, Brodin P, Rouillé Y, Tiegs G, Séron K, Moundipa PF.

Arch Virol. 2016 May;161(5):1169-81. doi: 10.1007/s00705-016-2771-5. Epub 2016 Feb 3.

PMID:
26843184
21.

Identification of class II ADP-ribosylation factors as cellular factors required for hepatitis C virus replication.

Farhat R, Séron K, Ferlin J, Fénéant L, Belouzard S, Goueslain L, Jackson CL, Dubuisson J, Rouillé Y.

Cell Microbiol. 2016 Aug;18(8):1121-33. doi: 10.1111/cmi.12572. Epub 2016 Feb 25.

PMID:
26814617
22.

Polyphenols Inhibit Hepatitis C Virus Entry by a New Mechanism of Action.

Calland N, Sahuc ME, Belouzard S, Pène V, Bonnafous P, Mesalam AA, Deloison G, Descamps V, Sahpaz S, Wychowski C, Lambert O, Brodin P, Duverlie G, Meuleman P, Rosenberg AR, Dubuisson J, Rouillé Y, Séron K.

J Virol. 2015 Oct;89(19):10053-63. doi: 10.1128/JVI.01473-15. Epub 2015 Jul 22.

23.

New Insights into the Understanding of Hepatitis C Virus Entry and Cell-to-Cell Transmission by Using the Ionophore Monensin A.

Fénéant L, Potel J, François C, Sané F, Douam F, Belouzard S, Calland N, Vausselin T, Rouillé Y, Descamps V, Baumert TF, Duverlie G, Lavillette D, Hober D, Dubuisson J, Wychowski C, Cocquerel L.

J Virol. 2015 Aug;89(16):8346-64. doi: 10.1128/JVI.00192-15. Epub 2015 Jun 3.

24.

Plant extracts from Cameroonian medicinal plants strongly inhibit hepatitis C virus infection in vitro.

Galani BR, Sahuc ME, Njayou FN, Deloison G, Mkounga P, Feudjou WF, Brodin P, Rouillé Y, Nkengfack AE, Moundipa PF, Séron K.

Front Microbiol. 2015 May 15;6:488. doi: 10.3389/fmicb.2015.00488. eCollection 2015.

25.

Hepatitis C virus life cycle and lipid metabolism.

Popescu CI, Riva L, Vlaicu O, Farhat R, Rouillé Y, Dubuisson J.

Biology (Basel). 2014 Dec 15;3(4):892-921. doi: 10.3390/biology3040892. Review.

26.

Regulation of core expression during the hepatitis C virus life cycle.

Afzal MS, Alsaleh K, Farhat R, Belouzard S, Danneels A, Descamps V, Duverlie G, Wychowski C, Zaidi Nu, Dubuisson J, Rouillé Y.

J Gen Virol. 2015 Feb;96(Pt 2):311-21. doi: 10.1099/vir.0.070433-0. Epub 2014 Oct 28.

PMID:
25351725
27.

Hepatitis C virus capsid protein and intracellular lipids interplay and its association with hepatic steatosis.

Afzal MS, Zaidi NU, Dubuisson J, Rouille Y.

Hepat Mon. 2014 Aug 11;14(8):e17812. doi: 10.5812/hepatmon.17812. eCollection 2014 Aug.

28.

Structure-activity studies of (-)-epigallocatechin gallate derivatives as HCV entry inhibitors.

Bhat R, Adam AT, Lee JJ, Deloison G, Rouillé Y, Séron K, Rotella DP.

Bioorg Med Chem Lett. 2014 Sep 1;24(17):4162-5. doi: 10.1016/j.bmcl.2014.07.051. Epub 2014 Jul 24.

PMID:
25103601
29.

FTO contributes to hepatic metabolism regulation through regulation of leptin action and STAT3 signalling in liver.

Bravard A, Vial G, Chauvin MA, Rouillé Y, Bailleul B, Vidal H, Rieusset J.

Cell Commun Signal. 2014 Jan 10;12:4. doi: 10.1186/1478-811X-12-4.

30.

Hepatitis C virus replication and Golgi function in brefeldin a-resistant hepatoma-derived cells.

Farhat R, Goueslain L, Wychowski C, Belouzard S, Fénéant L, Jackson CL, Dubuisson J, Rouillé Y.

PLoS One. 2013 Sep 18;8(9):e74491. doi: 10.1371/journal.pone.0074491. eCollection 2013.

31.

Hepatitis C virus and natural compounds: a new antiviral approach?

Calland N, Dubuisson J, Rouillé Y, Séron K.

Viruses. 2012 Oct 17;4(10):2197-217. doi: 10.3390/v4102197. Review.

32.

Hepatitis C virus assembly imaging.

Popescu CI, Rouillé Y, Dubuisson J.

Viruses. 2011 Nov;3(11):2238-54. doi: 10.3390/v3112238. Epub 2011 Nov 15. Review.

33.

Role of low-density lipoprotein receptor in the hepatitis C virus life cycle.

Albecka A, Belouzard S, Op de Beeck A, Descamps V, Goueslain L, Bertrand-Michel J, Tercé F, Duverlie G, Rouillé Y, Dubuisson J.

Hepatology. 2012 Apr;55(4):998-1007. doi: 10.1002/hep.25501.

PMID:
22121002
34.

(-)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry.

Calland N, Albecka A, Belouzard S, Wychowski C, Duverlie G, Descamps V, Hober D, Dubuisson J, Rouillé Y, Séron K.

Hepatology. 2012 Mar;55(3):720-9. doi: 10.1002/hep.24803.

PMID:
22105803
35.

Hepatocyte-derived cultured cells with unusual cytoplasmic keratin-rich spheroid bodies.

Delavalle PY, Alsaleh K, Pillez A, Cocquerel L, Allet C, Dumont P, Loyens A, Leteurtre E, Omary MB, Dubuisson J, Rouillé Y, Wychowski C.

Exp Cell Res. 2011 Nov 1;317(18):2683-94. doi: 10.1016/j.yexcr.2011.08.018. Epub 2011 Aug 31.

PMID:
21907707
36.

Endospanins regulate a postinternalization step of the leptin receptor endocytic pathway.

Séron K, Couturier C, Belouzard S, Bacart J, Monté D, Corset L, Bocquet O, Dam J, Vauthier V, Lecœur C, Bailleul B, Hoflack B, Froguel P, Jockers R, Rouillé Y.

J Biol Chem. 2011 May 20;286(20):17968-81. doi: 10.1074/jbc.M111.224857. Epub 2011 Mar 22.

37.

NS2 protein of hepatitis C virus interacts with structural and non-structural proteins towards virus assembly.

Popescu CI, Callens N, Trinel D, Roingeard P, Moradpour D, Descamps V, Duverlie G, Penin F, Héliot L, Rouillé Y, Dubuisson J.

PLoS Pathog. 2011 Feb 10;7(2):e1001278. doi: 10.1371/journal.ppat.1001278.

38.

Identification of basic amino acids at the N-terminal end of the core protein that are crucial for hepatitis C virus infectivity.

Alsaleh K, Delavalle PY, Pillez A, Duverlie G, Descamps V, Rouillé Y, Dubuisson J, Wychowski C.

J Virol. 2010 Dec;84(24):12515-28. doi: 10.1128/JVI.01393-10. Epub 2010 Oct 13.

39.

LEPROT and LEPROTL1 cooperatively decrease hepatic growth hormone action in mice.

Touvier T, Conte-Auriol F, Briand O, Cudejko C, Paumelle R, Caron S, Baugé E, Rouillé Y, Salles JP, Staels B, Bailleul B.

J Clin Invest. 2009 Dec;119(12):3830-8. doi: 10.1172/JCI34997. Epub 2009 Nov 9.

40.

Identification of GBF1 as a cellular factor required for hepatitis C virus RNA replication.

Goueslain L, Alsaleh K, Horellou P, Roingeard P, Descamps V, Duverlie G, Ciczora Y, Wychowski C, Dubuisson J, Rouillé Y.

J Virol. 2010 Jan;84(2):773-87. doi: 10.1128/JVI.01190-09. Epub 2009 Nov 11.

41.

Identification of a dominant endoplasmic reticulum-retention signal in yellow fever virus pre-membrane protein.

Ciczora Y, Callens N, Séron K, Rouillé Y, Dubuisson J.

J Gen Virol. 2010 Feb;91(Pt 2):404-14. doi: 10.1099/vir.0.015339-0. Epub 2009 Oct 21.

PMID:
19846669
42.

Silencing of OB-RGRP in mouse hypothalamic arcuate nucleus increases leptin receptor signaling and prevents diet-induced obesity.

Couturier C, Sarkis C, Séron K, Belouzard S, Chen P, Lenain A, Corset L, Dam J, Vauthier V, Dubart A, Mallet J, Froguel P, Rouillé Y, Jockers R.

Proc Natl Acad Sci U S A. 2007 Dec 4;104(49):19476-81. Epub 2007 Nov 27.

43.

Robust production of infectious viral particles in Huh-7 cells by introducing mutations in hepatitis C virus structural proteins.

Delgrange D, Pillez A, Castelain S, Cocquerel L, Rouillé Y, Dubuisson J, Wakita T, Duverlie G, Wychowski C.

J Gen Virol. 2007 Sep;88(Pt 9):2495-503.

PMID:
17698659
44.

Hepatitis C virus entry depends on clathrin-mediated endocytosis.

Blanchard E, Belouzard S, Goueslain L, Wakita T, Dubuisson J, Wychowski C, Rouillé Y.

J Virol. 2006 Jul;80(14):6964-72.

45.

Subcellular localization of hepatitis C virus structural proteins in a cell culture system that efficiently replicates the virus.

Rouillé Y, Helle F, Delgrange D, Roingeard P, Voisset C, Blanchard E, Belouzard S, McKeating J, Patel AH, Maertens G, Wakita T, Wychowski C, Dubuisson J.

J Virol. 2006 Mar;80(6):2832-41.

46.

Ubiquitylation of leptin receptor OB-Ra regulates its clathrin-mediated endocytosis.

Belouzard S, Rouillé Y.

EMBO J. 2006 Mar 8;25(5):932-42. Epub 2006 Feb 16.

47.

Interactions between virus proteins and host cell membranes during the viral life cycle.

Villanueva RA, Rouillé Y, Dubuisson J.

Int Rev Cytol. 2005;245:171-244. Review.

PMID:
16125548
48.

Bovine viral diarrhea virus entry is dependent on clathrin-mediated endocytosis.

Lecot S, Belouzard S, Dubuisson J, Rouillé Y.

J Virol. 2005 Aug;79(16):10826-9.

49.

Significance of prohormone convertase 2, PC2, mediated initial cleavage at the proglucagon interdomain site, Lys70-Arg71, to generate glucagon.

Dey A, Lipkind GM, Rouillé Y, Norrbom C, Stein J, Zhang C, Carroll R, Steiner DF.

Endocrinology. 2005 Feb;146(2):713-27. Epub 2004 Nov 4.

PMID:
15528303
50.

The transmembrane domains of the prM and E proteins of yellow fever virus are endoplasmic reticulum localization signals.

Op De Beeck A, Rouillé Y, Caron M, Duvet S, Dubuisson J.

J Virol. 2004 Nov;78(22):12591-602.

Supplemental Content

Loading ...
Support Center